Deutsch English Français

Contact

EP2972324

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2972324

EP2972324 - A NONINVASIVE METHOD FOR DIAGNOSING A DANDRUFF CONDITION [Right-click to bookmark this link]
Former [2016/03]	A NONINVASIVE METHOD FOR MEASURING OXIDATIVE STRESS AND OXIDATIVE DAMAGE FROM SKIN
	[2019/18]
Status	No opposition filed within time limit Status updated on 26.02.2021 Database last updated on 19.10.2024
Former	The patent has been granted Status updated on 20.03.2020
Former	Grant of patent is intended Status updated on 16.09.2019
Former	Examination is in progress Status updated on 28.08.2019
Former	Grant of patent is intended Status updated on 23.04.2019
Former	Examination is in progress Status updated on 24.03.2017
Most recent event Tooltip	06.09.2024	Lapse of the patent in a contracting state New state(s): MT	published on 09.10.2024 [2024/41]
Applicant(s)	For all designated states The Procter & Gamble Company One Procter & Gamble Plaza Cincinnati, OH 45202 / US
	[2016/03]
Inventor(s)	01 / KERR, Kathleen, Marie One Procter & Gamble Plaza Cincinnati Ohio 45202 / US
	02 / FIENO, Angela, Marie One Procter & Gamble Plaza Cincinnati Ohio 45202 / US
	03 / WEHMEYER, Kenneth, Robert One Procter & Gamble Plaza Cincinnati Ohio 45202 / US
	04 / LI, Lijuan One Procter & Gamble Plaza Cincinnati Ohio 45202 / US
	05 / SCHWARTZ, James, Robert One Procter & Gamble Plaza Cincinnati Ohio 45202 / US
	06 / GRANT, Raymond, Alan One Procter & Gamble Plaza Cincinnati Ohio 45202 / US
	[2020/17]
Former [2016/03]	01 / KERR, Kathleen, Marie One Procter&Gamble Plaza Cincinnati Ohio 45202 / US
	02 / FIENO, Angela, Marie One Procter&Gamble Plaza Cincinnati Ohio 45202 / US
	03 / WEHMEYER, Kenneth, Robert One Procter&Gamble Plaza Cincinnati Ohio 45202 / US
	04 / LI, Lijuan One Procter&Gamble Plaza Cincinnati Ohio 45202 / US
	05 / SCHWARTZ, James, Robert One Procter&Gamble Plaza Cincinnati Ohio 45202 / US
	06 / GRANT, Raymond, Alan One Procter&Gamble Plaza Cincinnati Ohio 45202 / US
Representative(s)	P&G Patent Germany Procter & Gamble Service GmbH Sulzbacher Straße 40 65824 Schwalbach am Taunus / DE
	[2020/17]
Former [2016/03]	Sauvaître, Thibault Bruno Procter & Gamble Service GmbH Patent Department PO Box 14 Frankfurter Straße 145 61476 Kronberg im Taunus / DE
Application number, filing date	14717367.8	14.03.2014
	[2016/03]
	WO2014US28598
Priority number, date	US201361793889P	15.03.2013 Original published format: US 201361793889 P
	[2016/03]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2014144265
	Date:	18.09.2014
	Language:	EN
	[2014/38]
	Type:	A1 Application with search report
	No.:	EP2972324
	Date:	20.01.2016
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 18.09.2014 takes the place of the publication of the European patent application.
	[2016/03]
	Type:	B1 Patent specification
	No.:	EP2972324
	Date:	22.04.2020
	Language:	EN
	[2020/17]
Search report(s)	International search report - published on:	EP	18.09.2014
Classification	IPC:	G01N33/50, C12Q1/28	[2019/18]
	CPC:	G01N33/5091 (EP,US); C12Q1/28 (EP,US); G01N33/5064 (EP,US); G01N33/92 (EP,US); G01N2800/20 (EP,US)
	Former IPC [2016/03]	G01N33/50
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/03]
Extension states	BA	Not yet paid
	ME	Not yet paid
Title	German:	NICHT-INVASIVES VERFAHREN ZUR DIAGNOSE VON KOPFSCHUPPEN	[2019/18]
	English:	A NONINVASIVE METHOD FOR DIAGNOSING A DANDRUFF CONDITION	[2019/18]
	French:	PROCÉDÉ NON INVASIF POUR LE DIAGNOSTIC DES PELLICULES	[2019/18]
	Former [2016/03]	NICHT-INVASIVES VERFAHREN ZUR MESSUNG VON OXIDATIVEM STRESS UND OXIDATIVER SCHÄDIGUNG DER HAUT
	Former [2016/03]	A NONINVASIVE METHOD FOR MEASURING OXIDATIVE STRESS AND OXIDATIVE DAMAGE FROM SKIN
	Former [2016/03]	PROCÉDÉ NON INVASIF POUR LA MESURE DU STRESS OXYDANT ET DE L'ENDOMMAGEMENT OXYDANT À PARTIR DE LA PEAU
Entry into regional phase	31.08.2015	National basic fee paid
	31.08.2015	Designation fee(s) paid
	31.08.2015	Examination fee paid
Examination procedure	31.08.2015	Examination requested [2016/03]
	29.04.2016	Amendment by applicant (claims and/or description)
	23.03.2017	Despatch of a communication from the examining division (Time limit: M06)
	26.09.2017	Reply to a communication from the examining division
	15.02.2018	Despatch of a communication from the examining division (Time limit: M04)
	25.05.2018	Reply to a communication from the examining division
	16.08.2018	Despatch of a communication from the examining division (Time limit: M04)
	28.12.2018	Reply to a communication from the examining division
	24.04.2019	Communication of intention to grant the patent
	08.08.2019	Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
	08.10.2019	Communication of intention to grant the patent
	03.02.2020	Fee for grant paid
	03.02.2020	Fee for publishing/printing paid
	03.02.2020	Receipt of the translation of the claim(s)
Divisional application(s)	EP17196627.8 / EP3287783
	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 23.03.2017
Opposition(s)	25.01.2021	No opposition filed within time limit [2021/13]
Fees paid	Renewal fee
	08.03.2016	Renewal fee patent year 03
	07.03.2017	Renewal fee patent year 04
	13.03.2018	Renewal fee patent year 05
	13.03.2019	Renewal fee patent year 06
	12.03.2020	Renewal fee patent year 07
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	HU	14.03.2014
	AL	22.04.2020
	AT	22.04.2020
	CY	22.04.2020
	CZ	22.04.2020
	DK	22.04.2020
	EE	22.04.2020
	ES	22.04.2020
	FI	22.04.2020
	HR	22.04.2020
	IT	22.04.2020
	LT	22.04.2020
	LV	22.04.2020
	MC	22.04.2020
	MK	22.04.2020
	MT	22.04.2020
	NL	22.04.2020
	PL	22.04.2020
	RO	22.04.2020
	RS	22.04.2020
	SE	22.04.2020
	SI	22.04.2020
	SK	22.04.2020
	SM	22.04.2020
	BG	22.07.2020
	NO	22.07.2020
	GR	23.07.2020
	IS	22.08.2020
	PT	24.08.2020
	[2024/41]
Former [2024/22]	HU	14.03.2014
	AL	22.04.2020
	AT	22.04.2020
	CY	22.04.2020
	CZ	22.04.2020
	DK	22.04.2020
	EE	22.04.2020
	ES	22.04.2020
	FI	22.04.2020
	HR	22.04.2020
	IT	22.04.2020
	LT	22.04.2020
	LV	22.04.2020
	MC	22.04.2020
	MK	22.04.2020
	NL	22.04.2020
	PL	22.04.2020
	RO	22.04.2020
	RS	22.04.2020
	SE	22.04.2020
	SI	22.04.2020
	SK	22.04.2020
	SM	22.04.2020
	BG	22.07.2020
	NO	22.07.2020
	GR	23.07.2020
	IS	22.08.2020
	PT	24.08.2020
Former [2023/30]	HU	14.03.2014
	AL	22.04.2020
	AT	22.04.2020
	CY	22.04.2020
	CZ	22.04.2020
	DK	22.04.2020
	EE	22.04.2020
	ES	22.04.2020
	FI	22.04.2020
	HR	22.04.2020
	IT	22.04.2020
	LT	22.04.2020
	LV	22.04.2020
	MC	22.04.2020
	NL	22.04.2020
	PL	22.04.2020
	RO	22.04.2020
	RS	22.04.2020
	SE	22.04.2020
	SI	22.04.2020
	SK	22.04.2020
	SM	22.04.2020
	BG	22.07.2020
	NO	22.07.2020
	GR	23.07.2020
	IS	22.08.2020
	PT	24.08.2020
Former [2023/27]	HU	14.03.2014
	AL	22.04.2020
	AT	22.04.2020
	CZ	22.04.2020
	DK	22.04.2020
	EE	22.04.2020
	ES	22.04.2020
	FI	22.04.2020
	HR	22.04.2020
	IT	22.04.2020
	LT	22.04.2020
	LV	22.04.2020
	MC	22.04.2020
	NL	22.04.2020
	PL	22.04.2020
	RO	22.04.2020
	RS	22.04.2020
	SE	22.04.2020
	SI	22.04.2020
	SK	22.04.2020
	SM	22.04.2020
	BG	22.07.2020
	NO	22.07.2020
	GR	23.07.2020
	IS	22.08.2020
	PT	24.08.2020
Former [2021/45]	AL	22.04.2020
	AT	22.04.2020
	CZ	22.04.2020
	DK	22.04.2020
	EE	22.04.2020
	ES	22.04.2020
	FI	22.04.2020
	HR	22.04.2020
	IT	22.04.2020
	LT	22.04.2020
	LV	22.04.2020
	MC	22.04.2020
	NL	22.04.2020
	PL	22.04.2020
	RO	22.04.2020
	RS	22.04.2020
	SE	22.04.2020
	SI	22.04.2020
	SK	22.04.2020
	SM	22.04.2020
	BG	22.07.2020
	NO	22.07.2020
	GR	23.07.2020
	IS	22.08.2020
	PT	24.08.2020
Former [2021/24]	AL	22.04.2020
	AT	22.04.2020
	CZ	22.04.2020
	DK	22.04.2020
	EE	22.04.2020
	ES	22.04.2020
	FI	22.04.2020
	HR	22.04.2020
	IT	22.04.2020
	LT	22.04.2020
	LV	22.04.2020
	NL	22.04.2020
	PL	22.04.2020
	RO	22.04.2020
	RS	22.04.2020
	SE	22.04.2020
	SI	22.04.2020
	SK	22.04.2020
	SM	22.04.2020
	BG	22.07.2020
	NO	22.07.2020
	GR	23.07.2020
	IS	22.08.2020
	PT	24.08.2020
Former [2021/10]	AL	22.04.2020
	AT	22.04.2020
	CZ	22.04.2020
	DK	22.04.2020
	EE	22.04.2020
	ES	22.04.2020
	FI	22.04.2020
	HR	22.04.2020
	IT	22.04.2020
	LT	22.04.2020
	LV	22.04.2020
	NL	22.04.2020
	PL	22.04.2020
	RO	22.04.2020
	RS	22.04.2020
	SE	22.04.2020
	SK	22.04.2020
	SM	22.04.2020
	BG	22.07.2020
	NO	22.07.2020
	GR	23.07.2020
	IS	22.08.2020
	PT	24.08.2020
Former [2021/09]	AL	22.04.2020
	AT	22.04.2020
	CZ	22.04.2020
	DK	22.04.2020
	EE	22.04.2020
	ES	22.04.2020
	FI	22.04.2020
	HR	22.04.2020
	IT	22.04.2020
	LT	22.04.2020
	LV	22.04.2020
	NL	22.04.2020
	RO	22.04.2020
	RS	22.04.2020
	SE	22.04.2020
	SM	22.04.2020
	BG	22.07.2020
	NO	22.07.2020
	GR	23.07.2020
	IS	22.08.2020
	PT	24.08.2020
Former [2021/08]	AL	22.04.2020
	DK	22.04.2020
	ES	22.04.2020
	FI	22.04.2020
	HR	22.04.2020
	LT	22.04.2020
	LV	22.04.2020
	NL	22.04.2020
	RO	22.04.2020
	RS	22.04.2020
	SE	22.04.2020
	SM	22.04.2020
	BG	22.07.2020
	NO	22.07.2020
	GR	23.07.2020
	IS	22.08.2020
	PT	24.08.2020
Former [2021/04]	AL	22.04.2020
	FI	22.04.2020
	HR	22.04.2020
	LT	22.04.2020
	LV	22.04.2020
	NL	22.04.2020
	RS	22.04.2020
	SE	22.04.2020
	BG	22.07.2020
	NO	22.07.2020
	GR	23.07.2020
	IS	22.08.2020
	PT	24.08.2020
Former [2021/01]	FI	22.04.2020
	HR	22.04.2020
	LT	22.04.2020
	LV	22.04.2020
	NL	22.04.2020
	RS	22.04.2020
	SE	22.04.2020
	BG	22.07.2020
	NO	22.07.2020
	GR	23.07.2020
	IS	22.08.2020
	PT	24.08.2020
Former [2020/51]	FI	22.04.2020
	HR	22.04.2020
	LT	22.04.2020
	LV	22.04.2020
	NL	22.04.2020
	RS	22.04.2020
	SE	22.04.2020
	NO	22.07.2020
	GR	23.07.2020
	IS	22.08.2020
	PT	24.08.2020
Former [2020/50]	FI	22.04.2020
	HR	22.04.2020
	LT	22.04.2020
	LV	22.04.2020
	NL	22.04.2020
	SE	22.04.2020
	NO	22.07.2020
	GR	23.07.2020
	IS	22.08.2020
	PT	24.08.2020
Former [2020/48]	FI	22.04.2020
	LT	22.04.2020
	NL	22.04.2020
	SE	22.04.2020
	NO	22.07.2020
	IS	22.08.2020
	PT	24.08.2020
Former [2020/47]	LT	22.04.2020
	NO	22.07.2020
	IS	22.08.2020
Former [2020/46]	IS	22.08.2020
Cited in	International search	[XI]US2010267825 (MALFROY-CAMINE BERNARD [US]) [X] 1-6 * example 2; claims 15-24,32-43 * [I] 7-15;
		[A] - TRUSH M A ET AL, "Myeloperoxidase as a biomarker of skin irritation and inflammation", FOOD AND CHEMICAL TOXICOLOGY, PERGAMON, GB, vol. 32, no. 2, doi:10.1016/0278-6915(94)90175-9, ISSN 0278-6915, (19940201), pages 143 - 147, (19940201), XP025532043 [A] 1-15 * the whole document * DOI: http://dx.doi.org/10.1016/0278-6915(94)90175-9
		[A] - JANG M ET AL, "EFFECTS OF RESVERATROL ON 12-O-TETRADECANOYLPHORBOL-13-ACETATE- INDUCED OXIDATIVE EVENTS AND GENE EXPRESSION IN MOUSE SKIN", CANCER LETTERS, NEW YORK, NY, US, (19981211), vol. 134, no. 1, doi:10.1016/S0304-3835(98)00250-X, ISSN 0304-3835, pages 81 - 89, XP000856519 [A] 1-15 * figure 1 * DOI: http://dx.doi.org/10.1016/S0304-3835(98)00250-X
		[A] - PERIHAN OZTURK ET AL, "Local oxidative stress in interdigital tinea pedis", THE JOURNAL OF DERMATOLOGY, (20130201), vol. 40, no. 2, doi:10.1111/1346-8138.12043, ISSN 0385-2407, pages 114 - 117, XP055125998 [A] 1-15 * the whole document * DOI: http://dx.doi.org/10.1111/1346-8138.12043
		[A] - KATHY KERR ET AL, "Epidermal changes associated with symptomatic resolution of dandruff: biomarkers of scalp health", INTERNATIONAL JOURNAL OF DERMATOLOGY, (20101223), vol. 50, no. 1, doi:10.1111/j.1365-4632.2010.04629.x, ISSN 0011-9059, pages 102 - 113, XP055031486 [A] 1-15 * the whole document * DOI: http://dx.doi.org/10.1111/j.1365-4632.2010.04629.x
		[A] - JIN-OK BAEK ET AL, "Assessment of an imiquimod-induced psoriatic mouse model in relation to oxidative stress", ARCHIVES OF DERMATOLOGICAL RESEARCH ; FOUNDED IN 1869 AS ARCHIV FÜR DERMATOLOGIE UND SYPHILIS, SPRINGER, BERLIN, DE, (20120805), vol. 304, no. 9, doi:10.1007/S00403-012-1272-Y, ISSN 1432-069X, pages 699 - 706, XP035130141 [A] 1-15 * the whole document * DOI: http://dx.doi.org/10.1007/s00403-012-1272-y
	Examination	WO2004041231
		US6262041
		- Perihan Ozturk ET AL, "ACTA DERMATOVENEROLOGICA CROATICA ACTA DERMATOVENEROLOGICA CROATICA Oxidative Stress in Patients with Scalp Seborrheic Dermatitis", Acta Dermatovenerol Croat, (20130217), vol. 21, no. 2, pages 80 - 85, XP055355386
	by applicant	- REDINBAUGH, M.G.; TURLEY, R.B., "Adaptation of the bicinchoninic acid protein assay for use with microtiter plates and sucrose gradient fractions", ANAL.BIOCHEM., (1986), vol. 153, doi:doi:10.1016/0003-2697(86)90091-6, pages 267 - 271, XP024821353 DOI: http://dx.doi.org/10.1016/0003-2697(86)90091-6

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p